PepJunkie Home of the Peptonauts
More

Peptide Atlas · Vitamin

Cholecalciferol (Vitamin D3)

In a five-year randomized, double-blind trial in 2,686 people aged 65 to 85, oral vitamin D3 (100,000 IU every four months) reduced first fractures at the hip, wrist, forearm or spine by a third compared with placebo.

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Summary

In a five-year randomized, double-blind trial in 2,686 people aged 65 to 85, oral vitamin D3 (100,000 IU every four months) reduced first fractures at the hip, wrist, forearm or spine by a third compared with placebo. · pmid:12609940

A meta-analysis of randomized trials found vitamin D3 more effective than vitamin D2 at raising serum 25-hydroxyvitamin D, especially when given as a bolus. · pmid:22552031

Identity

PubChem CID 5280795: Vitamin D3, C27H44O, 384.6 g/mol. · pubchem:5280795

CAS registry number 67-97-0. · pubchem:5280795

IUPAC name: (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol. · pubchem:5280795


Where the evidence actually sits

Established100%

Proportion of the 2 claims about Cholecalciferol (Vitamin D3) standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.


Living evidence history

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. (2003) · establishedComparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. (2012) · established20032012

2 resolved citations, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.


Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Cholecalciferol (Vitamin D3) yet.


Dose evidence, rung by rung

A studied human dose exists on file. Open the rung: the dose is the paper's, in its context, never PepJunkie's.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier
    • Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. · pmid 12609940 · 2003
    • Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. · pmid 22552031 · 2012
  3. Observational evidence · resolved human data at the emerging tier: thin, or contested

    nothing resolved on this rung

  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work

    nothing resolved on this rung

2 resolved citations, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.